Add to Watch ListAdd to Watch List Share This PageShare Email This Page Flag This PageFlag
477

Bionovo Overview

Edit Overview

Bionovo (NASDAQ: BNVI) is a drug development company focusing on the discovery of novel pharmaceutical agents for cancer and women's health. The company's strategy is to develop new drugs that it derives from natural substances used therapeutically in non-western medical practice. Bionovo's first drug is entering phase II clinical testing for menopause, its second has completed phase I clinical...More»

5858 Horton Street Suite 375 Emeryville, CA 94608 Map it »
510-601-2000
2002
Biopharmaceuticals
Corporation
Public

Funding

Edit Funding

Date Type Capital Amount Post-Money Valuation Investors
07/13/2006 Series A 1M Unknown

Products

No product information added yet. Add product information.

Related Companies

Page Information

02/18/2009 10:27AM by lzchang

v4 > v3 > v2 > v1 | See all versions

User Opinions

Bulls vs. Bears (0)

Bullish Opinions (0)
Be the first to tell us why they are destined to succeed
Bearish Opinions (0)
Be the first to tell us why they are destined to stumble.
Add your opinion

Add your opinion

Bullish
Bearish

Discussions (0)

Start a New Discussion

Start a New Discussion
Weekly Newsletter

Signup for the VentureBeat Profiles newsletter to receive top news and hot new startups of the week.

Opinion Poll
View All Opinions »
Overall, are you bullish or bearish on Bionovo?
vote bullish
vote bearish
Vote to see results or
Alexa Rank: n/a n/a
Yahoo Search Results: n/a  
News & Blogs
View All News »

There is no news right now.

Bionovo on Twitter
Twitter Search »

There are no discussions right now.

Embed Company Widget
Preview »

Add this company's information to your site.

Recent Contributors

There are no recent contributors to this company.

Related Jobs
loading...